English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

A clinical  Leclercia adecarboxylata  strain harboring the  mcr-4.3  and  bla  IMP-4  genes was isolated from active rectal screening of carbapenem-resistant Enterobacteriaceae (CRE) in a patient. The isolate was found to harbor seven plasmids, including a 94,635 bp  bla  IMP-4 -bearing IncN plasmid and a 9,782 bp  mcr-4.3 -bearing ColE10-type plasmid. The isolate was susceptible to colistin despite carrying the  mcr-4.3  gene, suggesting that this MCR-4 variant may not be functional. Carriage of antibiotic resistance genes in human gut  L. adecarboxylata  strain suggests that close surveillance of resistance strains in the human gut flora should be included as a routine clinical practice to prevent occurrence of infections, especially among immunocompromised patients.

Leclercia adecarboxylata From Human Gut Flora Carries mcr-4.3 and blaIMP-4-Bearing Plasmids